MEGPEP SFF Yeast Ferment Filtrate is produced from select yeast strains through high-density fermentation, cell disruption, and ultrafiltration, concentrating amino acids, micro-peptides, nucleotides, and organic acids.
Its nutrient spectrum is readily absorbed by keratinocytes to stimulate natural moisturizing factor (NMF) synthesis, gently soften rough keratin, and optimize surface microbiome equilibrium, leaving the complexion smooth, supple, and radiant.
In Vivo Data
In vivo zebrafish melanin quantitative test (significant reduction of melanin pigmentation).
RAW MATERIAL TECHNICAL & REGULATORY DOSSIER
Comprehensive Technical, Quality Specification, and Regulatory Dossier for R&D Formulators, Procurement, and Product Managers
📊
Biotechnology Mechanism & Scientific Evidence
Authoritative Brochure Technical Diagram · Molecular Model · Transdermal & Efficacy Mechanism
Mechanism DiagramComposite anti-aging oligopeptide matrix stimulating Type I/III collagen secretion and ROS clearance.
🔬
Formulation R&D Engineer Guide (R&D Technical Dossier)
Formulation Application · Physicochemical Parameters · Stability & Compatibility
| INCI Name (CN) |
裂殖酵母（SCHIZOSACCHAROMYCES）probiotic 丝体Fermentation Productssolution、1,2-1,2-Hexanediol |
INCI Name (EN) |
Schizosaccharomyces Ferment Filtrate, 1,2-Hexanediol |
| CAS No. |
6920-22-5 |
Recommended Dosage |
1.0% - 5.0% (Recommended 2.0% - 3.0%) |
| Optimal pH Range |
5.5 - 7.0 |
Thermal Processing |
Add below 40°C during final step; avoid high-pressure homogenization |
| Appearance & Odor |
Milky opalescent liquid with bluish Tyndall effect |
Solubility & Method |
Dispersible in water phase forming a uniform stable emulsion |
💡 Compatibility Guidelines & Precautions: Compatible with common emulsion and serum systems
📦
Procurement & Compliance Dossier (Procurement & Compliance)
NMPA Code · MOQ · Sampling Support · Certificate of Analysis
| NMPA Submission Code |
✓ 233510-00075-1952 |
Supply Packaging |
1kg/fluorinated bottle, 5kg/drum, 20kg/drum |
| Minimum Order Quantity (MOQ) |
1 kg (Ready Stock) |
Delivery Lead Time |
Dispatched within 24-48 hours |
| Storage Conditions |
Store refrigerated at 2-8°C, strictly sealed |
Shelf Life (Shelf Life) |
18 Months |
| R&D Sample Support |
Complimentary 30g trial sample available |
Quality Documentation |
Batch COA, SDS, TDS, NTA Nanoparticle Tracking Analysis Report |
💡
Product Planning & Marketing Highlights (Marketing Highlights)
Core Mechanism · Efficacy Claims · Recommended Formats · Scientific Backing
🧬 Core Bio-Tech Barrier & Mechanism of Action:
Utilizes 50-150nm biomimetic lipid bilayer nanovesicles that fuse with cell membranes, delivering concentrated signaling peptides directly into recipient fibroblasts to switch on collagen and elastin expression cascades.
✨ Key Selling Point Keywords:
🏷️ Exosome Peptide Micro-Encapsulation🏷️ Multi-Dimensional Revitalizing🏷️ Combating Photoaging & Dryness🏷️ Anti-Wrinkle & Firming🏷️ Balancing Skin Micro-Ecology
🧴 Recommended Product Formats & Categories:
Advanced regenerative serums, anti-wrinkle micro-emulsions, repair essence lotions, aesthetic post-care
📜 Patented Technologies & Scientific Backing:
Proprietary bio-fermentation exosome isolation and purification platform
⚖️
Regulatory Compliance & Peer-to-Peer Disclaimer
Regulatory & Professional Compliance Statement:
1. The raw material characteristics and experimental data (including cytological studies, mechanism diagrams, and literature citations) presented on this webpage are intended exclusively for technical discussion and formulation R&D reference by cosmetic brand formulators, R&D engineers, product planners, and academic research institutions. They do not constitute finished consumer cosmetic efficacy claims or commercial warranties.
2. Pursuant to the Regulations on the Supervision and Administration of Cosmetics, Standards for Cosmetic Efficacy Claim Evaluation, and relevant global cosmetic regulatory frameworks, cosmetic brand enterprises utilizing this raw material shall be solely responsible for the safety, stability, and efficacy claims of their finished consumer products, and shall independently complete efficacy evaluations and regulatory filings/registrations with the competent health authorities prior to commercial launch. Conclusions from in-vitro or cellular studies shall not be directly extrapolated as consumer claims.
3. Mellgen Biotech assumes no joint or indirect liability for any claims or regulatory non-compliance arising from improper customer formulation, unauthorized off-label claims, or unverified applications.
